Prediction Case File
YouTubeEvaluation Complete

Welcome to Czar Gets Crypto! Please note the following:

2 extracted signals · 2 resolved · 0 still active

C-Zar Gets Crypto  profile imageC-Zar Gets Crypto 27 Dec 2025, 21:51 UTC
Video preview for Welcome to Czar Gets Crypto! Please note the following:
Signals
2
Eligible signals in this source
Open
0
Still being tracked
Resolved
2
Evaluable outcomes
Successful
0
Canonical correct result
Failed
2
Canonical failed result
Resolved success
0%
Open and excluded signals omitted
Source overview

AI-generated source summary

The analysis focuses on ZECUSD and DASHUSD, identifying potential bullish continuation for ZECUSD with a target of $668.98 if it breaks above resistance at $535.50, with invalidation at $411.38. For DASHUSD, the analysis suggests a potential rebound to $51.11 from the $44.95 support zone, with invalidation below $38.71. The speaker notes that while positive momentum is observed, the sustainability of these moves depends on upcoming resistance levels and market behavior.

AI-generated summary based on the source content.

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  3. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

  4. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  5. Market predictions extracted

    2 eligible signals linked to this case.

  6. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

Extracted intelligence

Signals in this source

Continue the evidence trail
Analyst history

C-Zar Gets Crypto

Tracked signals
1743
Historical success
17.4%
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.